相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of dimethyl fumarate on neuroprotection and immunomodulation
Philipp Albrecht et al.
JOURNAL OF NEUROINFLAMMATION (2012)
T cells become licensed in the lung to enter the central nervous system
Francesca Odoardi et al.
NATURE (2012)
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Adam P. Gregory et al.
NATURE (2012)
Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
Rajneesh Srivastava et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
Ulf Schulze-Topphoff et al.
PLOS ONE (2012)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Insight into the mechanism of laquinimod action
W. Brueck et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
分享论文
